SensoLyte® Beta-amyloid Quantitative ELISA Kits

Products & Services

Our beta-amyloid quantitative ELISA kits are optimized to detect beta-amyloid fragments with high sensitivity, specificity and reproducibility.

The kits are optimized to detect human beta-Amyloid (1-40) and (1-42) peptides in human brain lysate, transgenic mouse brain lysate, human cerebrospinal fluid, plasma, or saliva. Wells are pre-coated with monoclonal anti-beta-Amyloid (1-40) or (1-42) specific capture antibodies and blocked with a proprietary blocking solution. The amount of human beta-Amyloid (1-40) or (1-42) is quantified using ELISA. Ample materials and reagents are provided to perform 96 assays.

Convenient One-Step Assay Format

  • Pre-coated and pre-blocked 96-well strip plate
  • Ready-to-use substrate solution and other assay components
  • One step assay (samples and detection antibodies are added simultaneously)
  • 1 hour assay time at room temperature (excluding incubation)

High Sensitivity

  • Detects as low as 2 pg/ml (13 fmoles/ml) of human beta-Amyloid (1-40) or (1-42)

Broad Dynamic Range

  • 3.9-250 pg/ml of human beta-Amyloid (1-40) or (1-42) peptide

Select your kits

Trending Now

New peptides for cardiovascular research : Kinins

Next post

Recommended for you

Cyclic Peptides: Structure, Uses, and Advan..

Products & Services

Cyclic peptides are reshaping drug development and research, offering unique advantages over their linear counterparts....
Continue Reading

Chelating Peptides for Radiopharmaceuticals..

Products & Services

Peptide-based radiopharmaceutical therapy (RPT), using chelating peptides to deliver radioisotopes directly to tumor sites, is...
Continue Reading

Annual Closing 2025

Company

Anaspec will be closed from Wednesday, December 24, 2025, through Friday, January 2, 2026....
Continue Reading